Insufficient scRNA-seq data for expression of SLC35D3 at single-cell level.
Insufficient scRNA-seq data for expression of SLC35D3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 82% | 34.48 | 791 / 966 | 60% | 7.39 | 315 / 527 |
stomach | 69% | 15.42 | 246 / 359 | 56% | 8.85 | 160 / 286 |
pancreas | 86% | 30.27 | 281 / 328 | 37% | 1.12 | 66 / 178 |
adrenal gland | 33% | 41.88 | 86 / 258 | 64% | 51.07 | 148 / 230 |
brain | 54% | 159.92 | 1423 / 2642 | 8% | 0.16 | 58 / 705 |
esophagus | 24% | 4.76 | 350 / 1445 | 22% | 2.34 | 40 / 183 |
skin | 27% | 3.34 | 493 / 1809 | 1% | 0.03 | 5 / 472 |
ovary | 2% | 0.24 | 3 / 180 | 23% | 0.68 | 99 / 430 |
bladder | 0% | 0 | 0 / 21 | 23% | 4.73 | 116 / 504 |
prostate | 20% | 2.74 | 48 / 245 | 1% | 0.01 | 3 / 502 |
lung | 10% | 1.98 | 56 / 578 | 9% | 0.62 | 106 / 1155 |
peripheral blood | 11% | 1.31 | 98 / 929 | 0% | 0 | 0 / 0 |
uterus | 2% | 0.16 | 3 / 170 | 8% | 0.29 | 35 / 459 |
breast | 4% | 0.38 | 17 / 459 | 5% | 0.12 | 53 / 1118 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.30 | 2 / 45 |
thymus | 2% | 0.19 | 14 / 653 | 2% | 0.04 | 13 / 605 |
spleen | 3% | 0.33 | 8 / 241 | 0% | 0 | 0 / 0 |
heart | 2% | 0.27 | 21 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 0.21 | 19 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
adipose | 1% | 0.11 | 13 / 1204 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 1 / 406 |
muscle | 0% | 0.02 | 1 / 803 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.00 | 1 / 901 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097009 | Biological process | energy homeostasis |
GO_0015786 | Biological process | UDP-glucose transmembrane transport |
GO_0060155 | Biological process | platelet dense granule organization |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_0032527 | Biological process | protein exit from endoplasmic reticulum |
GO_0055085 | Biological process | transmembrane transport |
GO_0070863 | Biological process | positive regulation of protein exit from endoplasmic reticulum |
GO_0031901 | Cellular component | early endosome membrane |
GO_0030672 | Cellular component | synaptic vesicle membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005460 | Molecular function | UDP-glucose transmembrane transporter activity |
GO_0015297 | Molecular function | antiporter activity |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
Gene name | SLC35D3 |
Protein name | Solute carrier family 35 member D3 (Fringe connection-like protein 1) |
Synonyms | FRCL1 |
Description | FUNCTION: Probable UDP-glucose transmembrane transporter involved in UDP-glucose transport from the cytosol to the lumen of synaptic vesicles . It is involved in platelet dense granules maturation (By similarity). .; FUNCTION: Alternatively, could function as a molecular adapter enhancing the formation of the PI3KC3-C1/AIC/autophagy initiation complex to promote autophagy in dopaminergic neurons. Could also regulate the plasma membrane localization of the D(1A) dopamine receptor/DRD1 and dopamine signaling. . |
Accessions | Q5M8T2 ENST00000331858.5 |